Clinical Trials List
2014-03-01 - 2016-01-20
Phase III
Terminated4
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Wen-Chi Chou Division of Hematology & Oncology
- 吳教恩 Division of Hematology & Oncology
- Tsai-Sheng Yang Division of Hematology & Oncology
- Chia-Hsun Hsieh Division of Hematology & Oncology
- Hung-Chih Hsu Division of Hematology & Oncology
- Wen-Chi Shen Division of Hematology & Oncology
- 黃文冠 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 林宗哲 Division of Hematology & Oncology
- 章明珠 Division of General Internal Medicine
- Ann-Lii Cheng Division of Hematology & Oncology
- SHIH-HUNG YANG Division of Hematology & Oncology
- SHIH-HUNG YANG Division of Hematology & Oncology
- 林育麟 Division of Hematology & Oncology
- 王秀伯 Division of General Internal Medicine
- Chih-Hung Hsu Division of Hematology & Oncology
- Yu-Wen Tien Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Yee Chao Division of Hematology & Oncology
- Rheun-Chuan Lee Division of Radiology
- Ming-Huang Chen Division of Hematology & Oncology
- Yi-Chen Yeh Division of Others -
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Yu-Li Su Division of Hematology & Oncology
- Shau-Hsuan Li Division of Hematology & Oncology
- 吳佳哲 Division of Hematology & Oncology
- 陳彥仰 Division of Hematology & Oncology
- 陳彥豪 Division of Hematology & Oncology
- 劉建廷 Division of Hematology & Oncology
- Tai-Jan Chiu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
250 participants
